MobilityPlus
Financiado
Commercialisation of the Connected Enteral Feeding Healthcare System for Integra...
Commercialisation of the Connected Enteral Feeding Healthcare System for Integrated Co ordinated Care Mobility
Mobility+ is the future of the enteral feeding healthcare. It is a solution that alleviates the burden on healthcare and addresses specific feeding needs of patients with Complex Chronic Conditions (CCCs). Mobility+ system will be...
Mobility+ is the future of the enteral feeding healthcare. It is a solution that alleviates the burden on healthcare and addresses specific feeding needs of patients with Complex Chronic Conditions (CCCs). Mobility+ system will be enabled by major advances in wireless technology, miniaturisation, nano-sensors and computing power, enabling the development of a connected medical device for enteral feeding care that can generate, collect, analyse and transmit data. The data, along with the Mobility+ devices themselves, are creating the Internet of Medical Things (IoMT) – a connected infrastructure of medical devices, software applications and health systems and services. This connectivity between Mobility+ sensors and devices will enable healthcare organisations to streamline their clinical operations and workflow management, and improve patient care, even from remote locations. It will disrupt existing business models of how enteral feed is sold and distributed. Due to elimination of hardware (external pump, batteries & other paraphernalia), simplicity of use, reduced maintenance and improved monitoring, Mobility+ will lower enteral feeding healthcare costs by up to 60%. It will provide significantly enhanced benefits to the user (patient) in terms of increased mobility and feeding efficiency - leading to radically improved quality of life. It will be the first and only solution that will provide enhanced usage control options and e-connectivity: enabling effective self-monitoring, better quality of care and improved diagnosis of side-effects. Mobility+ has already gained traction with target customers and end-users in US and Europe and Key Influencers.
ver más
Duración del proyecto: 30 meses
Fecha Inicio: 2020-04-22
Fecha Fin: 2022-10-31
Fecha Fin: 2022-10-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2022-10-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
2M€
Líder del proyecto
ROCKFIELD MEDICAL DEVICES LTD
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
507.46K€ |
Participante